Advertisement · 728 × 90

Posts by Lee Machado

Preview
Senior Microscopist and Facility Manager at University of Northampton Searching for an academic job? Explore this Senior Microscopist and Facility Manager opening on jobs.ac.uk! Click to view more details and browse other academic jobs.

We are after a Senior Microscopist and Facility Manager. This is a key Life science appointment for us so please send across your networks 🙌 www.jobs.ac.uk/job/DQX551/s...

4 weeks ago 0 0 0 0
Post image

Always happy to be back @unibirmingham.bsky.social . Today the fantastic Midlands Innovation Flow cytometry annual meeting! Looking forward to Chairing Session 3 with some fantastic academic and commercial speakers!

1 month ago 0 0 0 0
Preview
Inside Health - Unlocking the mystery of Epstein-Barr Virus - BBC Sounds How is EBV triggering autoimmune disease?

www.bbc.co.uk/sounds/play/...

2 months ago 0 0 0 0
Preview
Why academics should do more consulting — and how to make it work Encouraging academics to act as advisers to outside organizations is the most effective way to serve society’s needs.

www.nature.com/articles/d41...

3 months ago 0 0 0 0
Post image

Happy Christmas from our lab. Some projects funded, others not; some papers out, some still need to be written, some PhDs completed and others just beginning. We take the highs with the lows, let's see what 2026 brings...🎄🎅🌲

4 months ago 5 1 0 0
Preview
When goodbye comes too soon: How to wrap up science projects quickly Science projects are designed and funded on the scale of years, so what happens when researchers need to finish prematurely? This Community Page discusses solutions for quickly documenting partially f...

"Due to a variety of circumstances...many science projects will never be finished, despite years of invested resources and effort. By carefully and strategically documenting scientific work achieved, components of unfinished projects can be salvaged and preserved to benefit future researchers." 🧪

5 months ago 79 40 4 2

Looking forward to popping over for a nose at some point! 😉

5 months ago 1 0 0 0
Preview
Human Evolutionary Genetics Human Evolutionary Genetics reaches its third edition at a time when sequencing and analyzing whole genomes, modern and ancient, has become rapid, affordable, and routine. These advances have led to a...

Academics! Delighted to announce that the new 3rd edition of Human Evolutionary Genetics is now available to book inspection copies. Available to buy January 9th. 1/5
www.routledge.com/Human-Evolut...

7 months ago 12 4 3 1
Sweet signals, bitter truths: taste sensing and cardiovascular disease
Sweet signals, bitter truths: taste sensing and cardiovascular disease YouTube video by Anglia Ruskin University

www.youtube.com/watch?v=f9Vo...

6 months ago 0 0 0 0
YouTube Share your videos with friends, family, and the world

A fab inaugural from Prof Havovi Chichger. Sweet signals, bitter truths: taste sensing and cardiovascular disease youtube.com/live/f9VoIBqPP… via @YouTube

6 months ago 0 0 1 0
Advertisement
Preview
Epstein–Barr virus exploits desmocollin 2 as the principal epithelial cell entry receptor - Nature Microbiology A genome-wide CRISPR screen helps to identify the Epstein–Barr virus receptor desmocollin 2 for primary epithelial cell infection. Additional infection assays revealed that desmocollin 3 also aids infection.

Read the associated research article here: www.nature.com/articles/s41...

6 months ago 4 2 0 0
Preview
Identified receptors shed light on Epstein–Barr virus infection - Nature Microbiology Epstein–Barr virus is associated with cancer and implicated in autoimmune diseases. Three studies reveal desmocollin 2 and R9AP as receptors for Epstein–Barr virus infection, highlighting new avenues for targeted therapies.

#News&Views

Epstein–Barr virus is associated with cancer and implicated in autoimmune diseases. Three studies reveal desmocollin 2 and R9AP as receptors for Epstein–Barr virus infection, highlighting new avenues for targeted therapies.

#MicroSky 🦠

www.nature.com/articles/s41...

6 months ago 8 4 1 0
Preview
Epstein–Barr virus exploits desmocollin 2 as the principal epithelial cell entry receptor - Nature Microbiology A genome-wide CRISPR screen helps to identify the Epstein–Barr virus receptor desmocollin 2 for primary epithelial cell infection. Additional infection assays revealed that desmocollin 3 also aids infection.

www.nature.com/articles/s41...

6 months ago 2 0 0 0
Post image

Looking forward to using our new Seahorse across a bunch of projects for metabolic studies…just having to re-learn my undergraduate biochemistry though 😉

6 months ago 4 0 0 0
Post image

A unified model for Duchenne muscular dystrophy gene involvement in cancer: context-dependent tumour suppression and oncogenicity

🔦 buff.ly/lBnkwMP

🥼 @drleemachado.bsky.social

#CancerResearch #DuchenneMuscularDystrophy

6 months ago 1 1 0 0
Post image Post image

Great to catch up with my fab friend Tim (from our undergraduate days) who was recently promoted to Prof. in Structural Biology at the University of Birmingham.

7 months ago 3 0 0 0

Quite amusing sitting on a train overhearing two international scientists converse about cholera toxins, phage, E.Coli, yeast two hybrids…must be terrifying if you’re a non-scientist passenger sat in earshot 😂

7 months ago 2 0 0 0
Sixty Years of Discovery | Annual Reviews Each of us is a story. Mine is a story of doing science for 60 years, and I am honored to be asked to tell it. Even though this autobiography was written for the Annual Review of Immunology, I have ch...

www.annualreviews.org/content/jour...

7 months ago 0 0 0 0
Preview
David Baltimore, Nobel-Winning Molecular Biologist, Dies at 87

David Baltimore, Nobel-Winning Molecular Biologist, Dies at 87 www.nytimes.com/2025/09/07/s...

7 months ago 2 1 0 0
Preview
FEBS Press We propose a context-dependent model where the Duchenne muscular dystrophy (DMD) gene acts as a tumour suppressor in aggressive tumours and as an oncogene in less aggressive ones. We propose this mod...

8/8 Key message:
🧬 DMD is not uniformly oncogenic or tumour suppressive.
🧩 Isoform Dp71ab may be central.
📈 Any therapeutic approach must consider tumour context.

febs.onlinelibrary.wiley.com/doi/10.1002/...

8 months ago 0 0 0 0
Advertisement

7/8 For me, this project reflects pivoting in research. Learning bioinformatics during COVID provided the tools to take this forward, and collaborating with @Weekademia, it has now matured into a published study and a new framework to functionally test.

8 months ago 2 0 1 0
Post image

6/8 Supporting evidence:
Aggressive cancers often downregulate/mutate DMD.

Less aggressive cancers retain intact DMD.

So, DMD’s role is context-dependent.

8 months ago 0 0 1 0

5/8 From this, we propose a dual model:

In aggressive cancers, DMD acts as a tumour suppressor.

In less aggressive cancers, DMD can play an oncogenic role.

8 months ago 0 0 1 0
Post image

4/8 Pathway analysis revealed two contrasting patterns:

High DMD protective → ECM integrity & adhesion preserved.

High DMD harmful → morphogenesis & cellular plasticity promoted.

8 months ago 0 0 1 0
Post image

3/8 Isoform analysis was crucial:

Dp71ab was the dominant transcript and mirrored survival patterns.

Dp40 also appeared consistently.

This suggests isoforms, not just total DMD drive the biology.

8 months ago 0 0 1 0
Post image

2/8 Using TCGA data (33 cancers), we found DMD expression significantly linked to survival in 9 cancers.

But the direction split:

High DMD = ⬆️ survival (breast, lung, pancreas, AML, uveal melanoma)

High DMD = ⬇️ survival (glioma, thymoma, kidney and rectal)

8 months ago 0 0 1 0

1/8 The Duchenne muscular dystrophy gene (DMD) is well known in muscle biology, but in cancer its role has been puzzling.

Some studies showed high DMD = better survival. Others showed the opposite.

We set out to explain why.

8 months ago 0 0 1 0
Post image

🚨 New in FEBS Open Bio!
During COVID, with labs disrupted, I undertook an MRes apprenticeship in bioinformatics. As a professor, I was suddenly a student again, learning coding to support my group.

Together with @Weekademia, we propose a unified model of DMD in cancer. 🧵👇

8 months ago 4 0 1 1
Preview
The Day Novartis Chose Discovery How a Swiss pharma giant built the last great corporate research skunkworks - and why that model may never work again.

A formative experience for me working at Novartis for a year in the late 90s www.alexkesin.com/p/the-day-no... The Day Novartis Chose Discovery

8 months ago 1 0 0 0
Preview
Cytotoxic IgG: Mechanisms, functions, and applications Cytotoxic antibodies have become an essential tool to remove unwanted cells in patients with cancer, infection, and autoimmunity. Wöhner and Nimmerjahn summarize recent insights into how antibody-depe...

Cytotoxic IgG: Mechanisms, functions, and applications: Immunity www.cell.com/immunity/ful...

10 months ago 1 0 0 0
Advertisement